Representation Analysis of miRNA in Urine Microvesicles and Cell-Free Urine in Prostate Diseases
- 作者: Zaporozhchenko I.A.1,2, Bryzgunova O.E.1,2, Lekchnov E.A.1,2, Osipov I.D.3, Zaripov M.M.4, Yurchenko Y.B.1, Yarmoschuk S.V.2, Pashkovskaya O.A.2, Rykova E.Y.1,2, Zheravin A.A.2, Laktionov P.P.1,2
-
隶属关系:
- Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
- Meshalkin Siberian Federal Biomedical Research Center
- Novosibirsk State University
- Siberian District Medical Center
- 期: 卷 12, 编号 2 (2018)
- 页面: 156-163
- 栏目: Article
- URL: https://journals.rcsi.science/1990-7508/article/view/198203
- DOI: https://doi.org/10.1134/S1990750818020142
- ID: 198203
如何引用文章
详细
Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesicles-associated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urinary extracellular vesicles and demonstrated diagnostic potential of their miRNAs. In this study, we have performed a comparative analysis of 84 miRNA in paired samples of urine microvesicles and urine supernatant from healthy men, patients with benign prostate hyperplasia, and prostate cancer patients using miRCURY LNA miRNA qPCR Panels. In all groups of patients, miRNA subsets characterized by different distribution between the urinary fractions have been found. In this context, two groups of miRNAs have been identified, which are involved in several signaling pathways including those associated with prostate cancer development.
关键词
作者简介
I. Zaporozhchenko
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
编辑信件的主要联系方式.
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
O. Bryzgunova
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
E. Lekchnov
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
I. Osipov
Novosibirsk State University
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, Novosibirsk
M. Zaripov
Siberian District Medical Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, Novosibirsk
Yu. Yurchenko
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090
S. Yarmoschuk
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, Novosibirsk
O. Pashkovskaya
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, Novosibirsk
E. Rykova
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
A. Zheravin
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, Novosibirsk
P. Laktionov
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
俄罗斯联邦, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
补充文件
